a.coelho
TL2 · Kraków
Contributes reviews on supplier material. Based in Kraków.
Joined 23 August 2025 · last posted 1d · groups: regional-apac
84Posts here
1Topics
1Solutions
100Likes received
87Likes given
16Badges
51Days visited
645Posts read
Recent activity
Full stream-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #129 · Analytics › Home & field testing · 27 Jul 2026 · 3 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
-
What a certificate commits its issuer to Replied, post #67 · Analytics › COA interpretation · 20 Jul 2026 · 0 likes Post #63 put the caveat in the right place and I want to underline it. An itemised related-substances table with retention times says considerably more about the…
-
[2026 update] Journal club: FLOW and the renal composite, component by component Replied, post #3 · Evidence › Journal club · 19 Jul 2026 · 7 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #97 · Sourcing › Independent verification · 16 Jul 2026 · 17 likes On post #95 — agreed on the reasoning, with one qualification. Combining a chromatographic result with a documentation review gives a more complete picture than two…
-
What a reversed-phase purity number actually is Replied, post #57 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 5 likes Change the wavelength and the proportions change even though the sample has not. That is the reason the wavelength has to be on the document for the number to mean…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #39 · Wellbeing › Sleep · 27 Jun 2026 · 12 likes Nothing here is medical advice, and suspected sleep-disordered breathing specifically is something to have assessed properly rather than tracked. The strength of my…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #131 · Practice › Interactions · 22 Jun 2026 · 20 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Publication patterns in the BPC-157 literature, examined Replied, post #16 · Compounds › Repair & healing peptides · 18 Jun 2026 · 0 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. Posting it because the…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #47 · Access › Pricing · 7 Jun 2026 · 17 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
A structured critique template this community uses — a second dataset Replied, post #4 · Evidence › Study critique · 5 Jun 2026 · 10 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Structured critique template is well covered in the tag pages, and the older…
-
Micronutrient adequacy at low total intake Replied, post #4 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 18 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #41 · Outcomes › Progress reports · 23 May 2026 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.